Esmolol HCL IP / USP

Global Calcium is one of the leading manufacturers and exporters of Esmolol HCL CAS no. 81161-17-3, API, (Active Pharmaceutical Ingredient). We support the customers with exhaustive documentation. As a USDMF & EU-GMP certified global company and an established hallmark for pharmaceutical standards, Global Calcium has stood the test of time since its inception in 1979.

As manufacturer of Esmolol HCL we hereby state the following facts about the drug:

FDA- Approved for the treatment of; Perioperative and Postoperative Tachycardia and Hypertension and Supraventricular Tachycardia as well as Sinus Tachycardia.

Off-Label Use in the treatment of; Hypertensive Emergency, Aortic Dissection, Acute Coronary Syndrome, Electroconvulsive Therapy, Thyrotoxicosis, Intubation Cholinergic Response, Ventricular Tachycardia/Ventricular Fibrillation.

Esmolol does not require dosage adjustment for renal or hepatic impairment. 

Global Calcium is a leading manufacturer of this drug. We manufacture this pharmaceutical drug and make it available to domestic and overseas market